Quinolin-2-(1H)-ones
    7.
    发明授权
    Quinolin-2-(1H)-ones 失效
    喹啉-2-(1H) - 酮

    公开(公告)号:US6028080A

    公开(公告)日:2000-02-22

    申请号:US101837

    申请日:1998-07-17

    CPC分类号: C07D215/22 C07D401/10

    摘要: The invention relates to quinoline-2-(1H)-one derivatives of the general formula I ##STR1## in which R.sup.1, R.sup.2 and R.sup.3 are in each case independently of one another H, Hal, A or OA; R.sup.4 is H, --(CH.sub.2).sub.m --NR.sup.6 R.sup.7 ; R.sup.5 is H, --(CH.sub.2).sub.n --NR.sup.6 R.sup.7 ; R.sup.6 is H, A or, together with R.sup.7, --(CH.sub.2).sub.4 -- or --(CH.sub.2).sub.5 --; R.sup.7 is H, A or --(CH.sub.2).sub.m -- with a bond to the same ring or adjacent ring B or D or, together with R.sup.6, --(CH.sub.2).sub.4 -- or --(CH.sub.2).sub.5 --; X is --CHR.sup.5 --, --NR.sup.5 --, --O--, --S--; A is alkyl having 1-6 C atoms; Hal is F, Cl, Br or I; m is 1-3 and n is 0-3, where at least one of the two radicals R.sup.4 or R.sup.5 has the meaning --(CH.sub.2).sub.m --NR.sup.6 R.sup.7 or --(CH.sub.2).sub.n --NR.sup.6 R.sup.7, their enantiomers, stereoisomers, salts and solvates. Such compounds are useful for the treatment of neurodegenerative diseases.

    摘要翻译: PCT No.PCT / EP97 / 00084 Sec。 371日期:1998年7月17日 102(e)日期1998年7月17日PCT 1997年1月10日PCT PCT。 出版物WO97 / 26244 日期:1997年7月24日本发明涉及通式Ⅰ的喹啉-2-(1H) - 酮衍生物,其中R 1,R 2和R 3各自独立地为H,Hal,A或OA; R4是H, - (CH2)m-NR6R7; R5是H, - (CH2)n-NR6R7; R 6是H,A或与R 7一起, - (CH 2)4 - 或 - (CH 2)5 - R 7是H,A或 - (CH 2)m - ,其与相同的环或相邻的环B或D的键连接,或与R 6, - (CH 2)4 - 或 - (CH 2) X是-CHR 5 - , - NR 5 - , - O - , - S- A是具有1-6个C原子的烷基; Hal是F,Cl,Br或I; m是1-3,n是0-3,其中两个基团R4或R5中的至少一个具有含义 - (CH 2)m -NR 6 R 7或 - (CH 2)n -NR 6 R 7,它们的对映异构体,立体异构体,盐和溶剂合物 。 这些化合物可用于治疗神经变性疾病。

    1-(2-arylethyl)-pyrrolidines
    10.
    发明授权
    1-(2-arylethyl)-pyrrolidines 失效
    1-(2-芳乙基) - 吡咯烷

    公开(公告)号:US5232978A

    公开(公告)日:1993-08-03

    申请号:US786674

    申请日:1991-11-01

    摘要: Novel 1-(2-arylethyl)-pyrrolidines of the formula ##STR1## in which, Ar is a phenyl group which is unsubstituted or monosubstituted by OH, --O--CO--NH.sub.2, --O--CO--NHA, --O--CO--NA.sub.2, NH.sub.2, --NH--CHO, --NH--CO--A, --NH--CO--NH.sub.2, --NH--CO--NHA or NH--SO.sub.2 --A,R.sup.1 is A,R.sup.2 is a phenyl, naphthyl, thienyl, benzothienyl or pyridyl group which is unsubstituted or mono- or disubstituted by A, Hal, CF.sub.3, OH, OA, --O--CO--NH.sub.2, --O--CO--NHA, --O--CO--NA.sub.2, NO.sub.2, NH.sub.2, --NH--CHO, --NH--CO--A, --NH--CO--NH.sub.2, --NH--CO--NHA, --NH--SO.sub.2 A, --CO--A, --CONH.sub.2, --CONHA, --CONA.sub.2, --CH.sub.2 --CONH.sub.2 and/or --O--CH.sub.2 --CONH.sub.2,R.sup.3 is OH or CH.sub.2 OH,A is alkyl with 1-4 C atoms andHal is F, Cl, Br or I,or a pharmaceutically acceptable salt thereof for use as an analgesic in humans and veterinary medicine.

    摘要翻译: 具有下式的新颖的1-(2-芳基乙基) - 吡咯啉其中,Ar是未被取代或被OH,-O-CO-NH 2,-O-CO-NHA,-O- CO-NA2,NH2,-NH-CHO,-NH-CO-A,-NH-CO-NH2,-NH-CO-NHA或NH-SO2-A,R1是A,R2是苯基,萘基,噻吩基 ,未取代或被A,Hal,CF 3,OH,OA,-O-CO-NH 2,-O-CO-NHA,-O-CO-NA 2,NO 2,NH 2 - 取代的苯并噻吩基或吡啶基, NH-CHO,-NH-CO-A,-NH-CO-NH2,-NH-CO-NHA,-NH-SO2A,-CO-A,-CONH2,-CONHA,-CONA2,-CH2-CONH2和/ 或-O-CH 2 -CONH 2,R 3是OH或CH 2 OH,A是具有1-4个C原子的烷基,Hal是F,Cl,Br或I,或其药学上可接受的盐,用作人类和兽医学中的止痛剂 。